Stocks · Health care · Pharmaceutical Preparations

ALX ONCOLOGY HOLDINGS INC

ALXO Clue Score32
United States Fiscal year ends December CIK 0001810182 Results filed 6 Aug 2026

What the insiders did Net buying

By person

14 insiders · 224 transactions
1.8×

Jason Lettmann holds only 1.8 times base salary in stock. $1.35M of shares against $724.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Jason Lettmann last reported holding, valued at $1.93, the price Common Stock was last bought or sold at on the open market here, on 17 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Corey S Goodman
Director
$21.15M (2)
—
+$21.15M
8,914,849
$17.21M
—
G. Walmsley Graham
Director
$20.05M (2)
—
+$20.05M
2,161,981
$4.17M
—
Vivo Capital IX, LLC entity
10% owner
$18.53M (2)
—
+$18.53M
185,526
$358.07K
—
Robert J Adelman
10% owner
$16.21M (2)
—
+$16.21M
5,829,542
$11.25M
—
Jaume Pons
President & CSO
—
$10.84M (47)
−$10.84M
579,388
$1.12M
+9.1%
Peter S Garcia
Chief Financial Officer
$159.34K (2)
$6.57M (28) scheduled
−$6.41M
121,516
$234.53K
+2,066%
Jason Lettmann
Chief Executive Officer
$7.75M (5)
$13.63M (32)
−$5.89M
700,547
$1.35M
—
Sophia Randolph
Chief Medical Officer
—
$4.64M (34)
−$4.64M
325,711
$628.62K
+56.2%
LSV Associates, LLC entity
10% owner
$7.60M (2)
$5.99M (28)
+$1.61M
406,168
$783.90K
—
Shelly Wong
SVP, Finance and CAO
—
$158.01K (19)
−$158.01K
87,828
$169.51K
+487.5%
Rekha Hemrajani
Director
$103.40K (2)
—
+$103.40K
33,000
$63.69K
—
Harish Shantharam
Chief Financial Officer
$58.40K (1)
—
+$58.40K
75,000
$144.75K
—
Steffen Pietzke
VP Fin & Chief Acct Officer
$57.00K (1)
—
+$57.00K
3,000
$5.79K
—
Nathan Caffo
Chief Business Officer
—
—
—
11,254
$21.72K
+1,452%

No percentages here. This company's share count has moved by a factor of 2.6 over the window, from 53,444,020 to 138,276,997 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.